Characteristics | All (N = 39) | Response | p-value | ||||
No response (N = 19) | OAR (N = 20) | ||||||
No. | (%) | No. | (%) | No. | (%) | ||
Age (years) |
|
|
|
|
|
|
|
Mean ± SD | 57.79 | ±12.01 | 56.57 | ±11.45 | 58.95 | ±12.71 | 0.473• |
Median (Range) | 54 | (39 - 74) | 54 | (42 - 74) | 59 | (39 - 74) | |
≤60 years | 20 | (51.3%) | 10 | (50%) | 10 | (50%) | 0.869§ |
>60 years | 19 | (48.7%) | 9 | (47.4%) | 10 | (52.6%) | |
Sex |
|
|
|
|
|
|
|
Male | 23 | (59%) | 10 | (43.5%) | 13 | (56.5%) | 0.433§ |
Female | 16 | (41%) | 9 | (56.3%) | 7 | (43.8%) | |
Rai classification |
|
|
|
|
|
|
|
Stages 0, 1 & 2 | 16 | (41%) | 3 | (18.8%) | 13 | (81.3%) | 0.002§ |
Stages 3 & 4 | 23 | (59%) | 16 | (69.6%) | 7 | (30.4%) | |
Hepatomegally |
|
|
|
|
|
|
|
Absent | 21 | (53.8%) | 11 | (52.4%) | 10 | (47.6%) | 0.621§ |
Present | 18 | (46.2%) | 8 | (44.4%) | 10 | (55.6%) | |
Lymphadenopathy |
|
|
|
|
|
|
|
Absent | 13 | (33.3%) | 5 | (38.5%) | 8 | (61.5%) | 0.365§ |
Present | 26 | (66.6%) | 14 | (53.8%) | 12 | (46.2%) | |
Spleenomegally |
|
|
|
|
|
|
|
Absent | 9 | (23.1%) | 1 | (11.1%) | 8 | (88.9%) | 0.020§ |
Present | 30 | (76.9%) | 18 | (60%) | 12 | (40%) | |
WBCs (×103/mm3) |
|
|
|
|
|
|
|
Mean ± SD | 49.44 | ±33.21 | 47.46 | ±23.50 | 51.32 | ±40.93 | 0.407• |
Median (Range) | 36 | (17.50 - 122.80) | 43 | (17.50 - 112.50) | 32.35 | (17.50 - 122.80) | |
<100 × 103/mm3 | 33 | (84.6%) | 18 | (54.5%) | 15 | (45.5%) | 0.182§ |
≥100 × 103/mm3 | 6 | (15.4%) | 1 | (16.7%) | 5 | (83.3%) | |
Absolute lymphocytes (×103/mm3) |
|
|
|
|
|
|
|
Mean ± SD | 27.72 | ±17.09 | 26.61 | ±15.29 | 28.79 | ±18.97 | 0.855• |
Median (Range) | 19.30 | (9.10 - 67) | 19 | (13 - 67) | 21.15 | (9.10 - 67) | |
<30 × 103/mm3 | 27 | (69.2%) | 13 | (48.1%) | 14 | (51.9%) | 0.915§ |
≥30 × 103/mm3 | 12 | (30.8%) | 6 | (50%) | 6 | (50%) | |
Platelet count (×103/mm3) |
|
|
|
|
|
|
|
Mean ± SD | 121.61 | ±48.49 | 97.68 | ±33.79 | 144.35 | ±50.05 | 0.004• |
Median (Range) | 112 | (45 - 205) | 89 | (49 - 180) | 159.50 | (45 - 205) |